These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Non-invasive assessment of portal hypertension by multi-parametric magnetic resonance imaging of the spleen: A proof of concept study. Levick C; Phillips-Hughes J; Collier J; Banerjee R; Cobbold JF; Wang LM; Piechnik SK; Robson MD; Neubauer S; Barnes E; Pavlides M PLoS One; 2019; 14(8):e0221066. PubMed ID: 31430314 [TBL] [Abstract][Full Text] [Related]
5. MR elastography outperforms shear wave elastography for the diagnosis of clinically significant portal hypertension. Kennedy P; Stocker D; Carbonell G; Said D; Bane O; Hectors S; Abboud G; Cuevas J; Bolster BD; Friedman SL; Lewis S; Schiano T; Bhattacharya D; Fischman A; Thung S; Taouli B Eur Radiol; 2022 Dec; 32(12):8339-8349. PubMed ID: 35727321 [TBL] [Abstract][Full Text] [Related]
6. Noninvasive assessment of clinically significant portal hypertension using ΔT1 of the liver and spleen and ECV of the spleen on routine Gd-EOB-DTPA liver MRI. Catucci D; Obmann VC; Berzigotti A; Gräni C; Guensch DP; Fischer K; Ebner L; Heverhagen JT; Christe A; Huber AT Eur J Radiol; 2021 Nov; 144():109958. PubMed ID: 34571458 [TBL] [Abstract][Full Text] [Related]
7. 3D T1 relaxometry pre and post gadoxetic acid injection for the assessment of liver cirrhosis and liver function. Besa C; Bane O; Jajamovich G; Marchione J; Taouli B Magn Reson Imaging; 2015 Nov; 33(9):1075-1082. PubMed ID: 26119422 [TBL] [Abstract][Full Text] [Related]
8. T1 mapping for liver function evaluation in gadoxetic acid-enhanced MR imaging: comparison of look-locker inversion recovery and B Kim JE; Kim HO; Bae K; Choi DS; Nickel D Eur Radiol; 2019 Jul; 29(7):3584-3594. PubMed ID: 30903328 [TBL] [Abstract][Full Text] [Related]
9. Performance of liver surface nodularity quantification for the diagnosis of portal hypertension in patients with cirrhosis: comparison between MRI with hepatobiliary phase sequences and CT. De Vos N; Sartoris R; Cauchy F; Rautou PE; Vilgrain V; Ronot M Abdom Radiol (NY); 2020 Feb; 45(2):365-372. PubMed ID: 31797023 [TBL] [Abstract][Full Text] [Related]
10. Noninvasive prediction of portal pressure with MR elastography and DCE-MRI of the liver and spleen: Preliminary results. Wagner M; Hectors S; Bane O; Gordic S; Kennedy P; Besa C; Schiano TD; Thung S; Fischman A; Taouli B J Magn Reson Imaging; 2018 Oct; 48(4):1091-1103. PubMed ID: 29638020 [TBL] [Abstract][Full Text] [Related]
11. Diagnosis of Clinically Significant Portal Hypertension Using CT- and MRI-based Vascular Model. Wang C; Huang Y; Liu C; Liu F; Hu X; Kuang X; An W; Liu C; Liu Y; Liu S; He R; Wang H; Qi X Radiology; 2023 Apr; 307(2):e221648. PubMed ID: 36719293 [TBL] [Abstract][Full Text] [Related]
12. Relationship between magnetic resonance imaging spleen T1 relaxation and other radiologic and clinical biomarkers of liver fibrosis in children and young adults with autoimmune liver disease. Dillman JR; Tkach JA; Gandhi D; Singh R; Miethke AG; Jayaswal A; Trout AT Abdom Radiol (NY); 2020 Nov; 45(11):3709-3715. PubMed ID: 32328693 [TBL] [Abstract][Full Text] [Related]
13. Non-invasive aspartate aminotransferase to platelet ratio index correlates well with invasive hepatic venous pressure gradient in cirrhosis. Kirnake V; Arora A; Sharma P; Goyal M; Chawlani R; Toshniwal J; Kumar A Indian J Gastroenterol; 2018 Jul; 37(4):335-341. PubMed ID: 30178093 [TBL] [Abstract][Full Text] [Related]
14. Portal hypertension may influence the registration of hypointensity of small hepatocellular carcinoma in the hepatobiliary phase in gadoxetic acid MR. Caparroz C; Forner A; Rimola J; Darnell A; García-Criado Á; Ayuso JR; Reig M; Bruix J; Ayuso C Radiol Oncol; 2022 Aug; 56(3):292-302. PubMed ID: 35776837 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of Liver and Spleen Stiffness with Acoustic Radiation Force Impulse Quantification Elastography for Diagnosing Clinically Significant Portal Hypertension. Attia D; Schoenemeier B; Rodt T; Negm AA; Lenzen H; Lankisch TO; Manns M; Gebel M; Potthoff A Ultraschall Med; 2015 Dec; 36(6):603-10. PubMed ID: 26565516 [TBL] [Abstract][Full Text] [Related]
16. Non-invasive detection of portal hypertension by enhanced liver fibrosis score in patients with different aetiologies of advanced chronic liver disease. Simbrunner B; Marculescu R; Scheiner B; Schwabl P; Bucsics T; Stadlmann A; Bauer DJM; Paternostro R; Eigenbauer E; Pinter M; Stättermayer AF; Trauner M; Mandorfer M; Reiberger T Liver Int; 2020 Jul; 40(7):1713-1724. PubMed ID: 32358998 [TBL] [Abstract][Full Text] [Related]
17. Non-invasive assessment of portal hypertension using quantitative magnetic resonance imaging. Palaniyappan N; Cox E; Bradley C; Scott R; Austin A; O'Neill R; Ramjas G; Travis S; White H; Singh R; Thurley P; Guha IN; Francis S; Aithal GP J Hepatol; 2016 Dec; 65(6):1131-1139. PubMed ID: 27475617 [TBL] [Abstract][Full Text] [Related]
18. Liver and spleen transient elastography predicts portal hypertension in patients with chronic liver disease: a prospective cohort study. Zykus R; Jonaitis L; Petrenkienė V; Pranculis A; Kupčinskas L BMC Gastroenterol; 2015 Dec; 15():183. PubMed ID: 26702818 [TBL] [Abstract][Full Text] [Related]
19. Quantification of Liver Surface Nodularity at CT: Utility for Detection of Portal Hypertension. Sartoris R; Rautou PE; Elkrief L; Pollorsi G; Durand F; Valla D; Spahr L; Terraz S; Soubrane O; Cauchy F; Vilgrain V; Ronot M Radiology; 2018 Dec; 289(3):698-707. PubMed ID: 30179109 [TBL] [Abstract][Full Text] [Related]
20. Magnetic resonance parametric mapping of the spleen for non-invasive assessment of portal hypertension. Mesropyan N; Isaak A; Faron A; Praktiknjo M; Jansen C; Kuetting D; Meyer C; Pieper CC; Sprinkart AM; Chang J; Maedler B; Thomas D; Kupczyk P; Attenberger U; Luetkens JA Eur Radiol; 2021 Jan; 31(1):85-93. PubMed ID: 32749584 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]